Q1 2024: Merck KGaA cites volatile CDMO biz and destocking for declined sales
For the first quarter 2024, MilliporeSigma, the life sciences division of Merck KGaA, reported €2.1 billion ($2.3 billion) in sales for its, a decrease of 13.8% year-on-year. While the firm said the results are “in line with expectation of a softer first …